Deleted Tweets From Scott Gottlieb, R-D.C.

Everyone who seeks treatment for opioid use disorder deserves to be offered all 3 medication-assisted treatment options to allow patients and providers to select the treatment best suited to the needs of each patient. Learn more about MAT: https://t.co/6K

My remarks from today #NCCN summit focus on the need to modernize drug development to harness the full medical potential of rapidly advancing science: https://t.co/27B7CtqRNb

Cancer may be the field where the medical benefits and fiscal challenges of rapid cycle innovation are most apparent, my remarks at #NCCN discuss this important topic: https://t.co/27B7CtqRNb

At #FDA we’re focused on how we can continue to make the science of drug development modern and patient-centered so that approved products impact the features of disease patients and families value most #NCCN: https://t.co/27B7CtqRNb

RT @NCCNnews: Thank you to FDA Commissioner @SGottliebFDA for sharing these thoughts on Accelerating Access to Innovation during… https://t.co/aTz3x8buqk

#FDA is reporting additional kratom-containing products have been found to be contaminated with Salmonella. More info on the brands/companies assoc. with newly reported products & the agency’s concerns about the safety risks of kratom is available onl

On June 25, 1938, the Federal Food, Drug & Cosmetic Act was passed. This law played a major role in the evolution of food and drug law in the U.S. and dramatically strengthened protections for American consumers. LEARN MORE: https://t.co/QCmjGVGkzr #F

In addition to concerns raised by Salmonella outbreak, #FDA continues to warn against consuming any kratom product. There are no FDA-approved uses for kratom and the agency has received concerning reports about its safety, incl. deaths assoc. with its use

Looking forward to the #FDA Online Opioid summit on Wed. where we will discuss and collaborate with internet stakeholders on solutions to stop the illegal sale of opioids online – an issue which is helping fuel America’s opioid crisis and must be addresse

Adequate and well-controlled clinical studies helped lead to FDA’s approval of the first CBD drug product. FDA actively supports drug developers wanting to investigate marijuana or its components for potentially safe and effective medical uses https://t.c

#FDA continues to take action against unapproved products claiming to contain cannabidiol and marketed to treat or cure serious diseases. These products have no scientific evidence to support such claims and are illegal: https://t.co/sIlQaZbYBq

Today’s approval of a cannabidiol drug product marks an important medical advancement. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana: https://t.co/RwWAljY1qd

RT @FDASpox: Checkout the latest updates to FDA's list of off-patent, off-exclusivity drugs w/o approved generics https://t.co/Qv0Du9QNrb QT @SGottliebFDA: Today we updated our list of off-patent, off-exclusivity drugs for which there are no approved generic versions. We… https://t.co/gtCv0kqnTp)

On average, 115 Americans die every day from an opioid overdose.  Increasingly people are buying opioids online including Vicodin or Percocet or Oxycontin, but what we believe they’re really getting is pressed fentanyl at doses that can be lethal. https:/

For #FDA the area of our most concerted focus are illicit drugs sold online and typically shipped through the mail. This is where we believe we have a significant role to play and where the agency is stepping up our work. https://t.co/iO6RlAiL59

Today, #FDA is joined by dozens of participants representing internet stakeholders, government entities, academic researchers and advocacy groups to discuss ways to collaboratively reduce the availability of illicit opioids online. https://t.co/iO6RlAiL59

FDA continues to spur the development of new antibiotics, especially when there is an unmet need https://t.co/UQgYKIOKym

#FDA’s efforts include working collaboratively with responsible Internet stakeholders who share our concerns and our commitment to public health to address issues of abuse and misuse and stemming the flow of illegal opioids sold online. https://t.co/iO6Rl

Tomorrow, we’ll be providing a summary of the robust conversation and general ideas from #FDA’s Online Opioid Summit. We’re committed to cracking down on the illegal sale of opioids online, but success will require partnership with all stakeholders. https

Today #FDA is hosting a public workshop is to discuss clinical trial designs for inhaled antibacterial products to treat pulmonary diseases. Join the meeting online: https://t.co/w8TkEu9K5k

Everyone who seeks treatment for opioid use disorder deserves to be offered all 3 medication-assisted treatment options to allow patients and providers to select the treatment best suited to the needs of each patient. Learn more about MAT: https://t.co/6K

My remarks from today #NCCN summit focus on the need to modernize drug development to harness the full medical potential of rapidly advancing science: https://t.co/27B7CtqRNb

Cancer may be the field where the medical benefits and fiscal challenges of rapid cycle innovation are most apparent, my remarks at #NCCN discuss this important topic: https://t.co/27B7CtqRNb

At #FDA we’re focused on how we can continue to make the science of drug development modern and patient-centered so that approved products impact the features of disease patients and families value most #NCCN: https://t.co/27B7CtqRNb

RT @NCCNnews: Thank you to FDA Commissioner @SGottliebFDA for sharing these thoughts on Accelerating Access to Innovation during… https://t.co/aTz3x8buqk

#FDA is reporting additional kratom-containing products have been found to be contaminated with Salmonella. More info on the brands/companies assoc. with newly reported products & the agency’s concerns about the safety risks of kratom is available onl

On June 25, 1938, the Federal Food, Drug & Cosmetic Act was passed. This law played a major role in the evolution of food and drug law in the U.S. and dramatically strengthened protections for American consumers. LEARN MORE: https://t.co/QCmjGVGkzr #F

In addition to concerns raised by Salmonella outbreak, #FDA continues to warn against consuming any kratom product. There are no FDA-approved uses for kratom and the agency has received concerning reports about its safety, incl. deaths assoc. with its use

Looking forward to the #FDA Online Opioid summit on Wed. where we will discuss and collaborate with internet stakeholders on solutions to stop the illegal sale of opioids online – an issue which is helping fuel America’s opioid crisis and must be addresse

Adequate and well-controlled clinical studies helped lead to FDA’s approval of the first CBD drug product. FDA actively supports drug developers wanting to investigate marijuana or its components for potentially safe and effective medical uses https://t.c

#FDA continues to take action against unapproved products claiming to contain cannabidiol and marketed to treat or cure serious diseases. These products have no scientific evidence to support such claims and are illegal: https://t.co/sIlQaZbYBq

Today’s approval of a cannabidiol drug product marks an important medical advancement. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana: https://t.co/RwWAljY1qd

RT @FDASpox: Checkout the latest updates to FDA's list of off-patent, off-exclusivity drugs w/o approved generics https://t.co/Qv0Du9QNrb QT @SGottliebFDA: Today we updated our list of off-patent, off-exclusivity drugs for which there are no approved generic versions. We… https://t.co/gtCv0kqnTp)

On average, 115 Americans die every day from an opioid overdose.  Increasingly people are buying opioids online including Vicodin or Percocet or Oxycontin, but what we believe they’re really getting is pressed fentanyl at doses that can be lethal. https:/

For #FDA the area of our most concerted focus are illicit drugs sold online and typically shipped through the mail. This is where we believe we have a significant role to play and where the agency is stepping up our work. https://t.co/iO6RlAiL59

Today, #FDA is joined by dozens of participants representing internet stakeholders, government entities, academic researchers and advocacy groups to discuss ways to collaboratively reduce the availability of illicit opioids online. https://t.co/iO6RlAiL59

FDA continues to spur the development of new antibiotics, especially when there is an unmet need https://t.co/UQgYKIOKym

#FDA’s efforts include working collaboratively with responsible Internet stakeholders who share our concerns and our commitment to public health to address issues of abuse and misuse and stemming the flow of illegal opioids sold online. https://t.co/iO6Rl

Tomorrow, we’ll be providing a summary of the robust conversation and general ideas from #FDA’s Online Opioid Summit. We’re committed to cracking down on the illegal sale of opioids online, but success will require partnership with all stakeholders. https

Today #FDA is hosting a public workshop is to discuss clinical trial designs for inhaled antibacterial products to treat pulmonary diseases. Join the meeting online: https://t.co/w8TkEu9K5k